Patents by Inventor Aron H. Lichtman

Aron H. Lichtman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fatty acid amides and uses thereof in the treatment of addiction disorder and addiction related conditions
    Patent number: 11324709
    Abstract: The present invention is directed to a fatty acid amide of an amino acid, including a stereoisomer and a salt thereof for use in the treatment of a patient suffering from any type of addiction disorder, substance abuse disorder, including any condition and symptom associated therewith and including withdrawal syndrome and relapse addiction during and after a rehabilitation treatment of said patient.
    Type: Grant
    Filed: May 22, 2018
    Date of Patent: May 10, 2022
    Assignee: Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
    Inventors: Raphael Mechoulam, Vincenzo Di Marzo, Fabiana Piscitelli, Aron H. Lichtman, Imad M. Damaj, Linda Parker, Rami Yaka
  • FATTY ACID AMIDES AND USES THEREOF IN THE TREATMENT OF ADDICTION DISORDER AND ADDICTION RELATED CONDITIONS
    Publication number: 20200108037
    Abstract: The present invention is directed to a fatty acid amide of an amino acid, including a stereoisomer and a salt thereof for use in the treatment of a patient suffering from any type of addiction disorder, substance abuse disorder, including any condition and symptom associated therewith and including withdrawal syndrome and relapse addiction during and after a rehabilitation treatment of said patient.
    Type: Application
    Filed: May 22, 2018
    Publication date: April 9, 2020
    Applicants: Yissum Research Development Company of The Hebrew University of Jerusalem Ltd., VIRGINIA COMMONWEALTH UNIVERSITY, UNIVERSITY OF GUELPH
    Inventors: Raphael MECHOULAM, Vincenzo DI MARZO, Fabiana PISCITELLI, Aron H. LICHTMAN, Imad M. DAMAJ, Linda PARKER, Rami YAKA
  • Delta9 tetrahydrocannabinol (delta9 THC) solution metered dose inhalers and methods of use
    Publication number: 20040258622
    Abstract: The present invention provides therapeutic formulations for solutions of &Dgr;9-tetrahydrocannabinol (&Dgr;9 THC) to be delivered by metered dose inhalers. The formulations, which use non-CFC propellants, provide a stable aerosol-deliverable source of &Dgr;9 THC for the treatment of various medical conditions, such as: nausea and vomiting associated with chemotherapy-muscle spasticity; pain; anorexia associated with AIDS wasting syndrome, epilepsy; glaucoma; bronchial asthma; and mood disorders.
    Type: Application
    Filed: January 20, 2004
    Publication date: December 23, 2004
    Inventors: Joanne Peart, Peter R. Byron, Aron H. Lichtman, Billy R. Martin
  • &Dgr;9 tetrahydrocannabinol (&Dgr;9 THC) solution metered dose inhalers and methods of use
    Patent number: 6713048
    Abstract: The present invention provides therapeutic formulations for solutions of &Dgr;9-tetrahydrocannabinol (&Dgr;9 THC) to be delivered by metered dose inhalers. The formulations, which use, non-CFC propellants, provide a stable aerosol-deliverable source of &Dgr;9 THC for the treatment of various medical conditions, such as: nausea and vomiting associated with chemotherapy-muscle spasticity; pain; anorexia associated with AIDS wasting syndrome, epilepsy; glaucoma; bronchial asthma; and mood disorders.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: March 30, 2004
    Assignee: Virginia Commonwealth University
    Inventors: Joanne Peart, Peter R. Byron, Aron H. Lichtman, Billy R. Martin
  • &Dgr;9 Tetrahydrocannabinol (&Dgr;9 THC) solution metered dose inhaler
    Patent number: 6509005
    Abstract: The present invention provides therapeutic formulations for solutions of &Dgr;9-tetrahydrocannabinol (&Dgr;9 THC) to be delivered by metered dose inhalers. The formulations, which utilize non-CFC propellants, provide a stable aerosol-deliverable source of &Dgr;9 THC for the treatment of various medical conditions, such as: nausea and vomiting associated with chemotherapy; muscle spasticity; pain; anorexia associated with AIDS wasting syndrome; epilepsy; glaucoma; bronchial asthma; and mood disorders.
    Type: Grant
    Filed: March 22, 1999
    Date of Patent: January 21, 2003
    Assignee: Virginia Commonwealth University
    Inventors: Joanne Peart, Peter R. Byron, Aron H. Lichtman, Billy R. Martin
  • Delta9 tetrahydrocannabinol (Delta9 THC) solution metered dose inhalers and methods of use
    Publication number: 20020031480
    Abstract: The present invention provides therapeutic formulations for solutions of &Dgr;9-tetrahydrocannabinol (&Dgr;9 THC) to be delivered by metered dose inhalers. The formulations, which use non-CFC propellants, provide a stable aerosol-deliverable source of &Dgr;9 THC for the treatment of various medical conditions, such as: nausea and vomiting associated with chemotherapy—muscle spasticity; pain; anorexia associated with AIDS wasting syndrome, epilepsy; glaucoma; bronchial asthma; and mood disorders.
    Type: Application
    Filed: September 4, 2001
    Publication date: March 14, 2002
    Inventors: Joanne Peart, Peter R. Byron, Aron H. Lichtman, Billy R. Martin